Article: QIAGEN Products Adopted by Major Testing Centers Worldwide for Use in Avian Flu Surveillance.

VENLO, The Netherlands, February 13 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the world's premier supplier of solutions for preanalytical sample preparation, today announced rapid adoption of its broad product portfolio in avian flu (H5N1) detection and surveillance by major testing centers worldwide.

In a survey conducted at year-end 2005, QIAGEN has established that more than 80 institutions are now using QIAGEN preanalytical products and test kits as standard tools in their surveillance programs. QIAGEN believes that this represents a significant majority of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!